Skip to content

Protagonist Therapeutics, Inc

PTGX· NasdaqCore metricsCIK 1377121

Pharmaceutical preparations552 peers

Last sale
Nov 12, 2026 · -0.49%
Market cap
$8.77B
65.27M shares
Filings
707
$274.41M
Q3 2026−89.4% FY25 yoy
$220.02M
Q3 2026N/M FY25 yoy
$218.33M
Q3 2026N/M FY25 yoy
$146.27M
Q3 2026derived−69.3% FY25 yoy
$3.07
Q3 2026N/M FY25 yoy
$498.30M
Q3 2026+32.0% FY25 yoy
$8.77B
25.6×
15.9×
8.1×
1.25%
—

Twelve months to Sep 30, 2026 · derived

Price

$134.31+57.17%+$48.86past year
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$46.02MFY 2025
$434.43M0FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31$46,016,000reported
FY 20242024-12-31$434,433,000reported
FY 20232023-12-31$60,000,000reported
FY 20222022-12-31$26,581,000reported
FY 20212021-12-31$27,357,000reported
FY 20202020-12-31$28,628,000reported
FY 20192019-12-31$231,000reported
FY 20182018-12-31$30,925,000reported
FY 20172017-12-31$20,063,000reported

Pharmaceutical preparations

Protagonist Therapeutics, Inc is the 130th largest of the 553 covered companies the SEC files under this code, by revenue. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Protagonist Therapeutics, Inc · CIK 1377121 · Engraved from SEC EDGAR